
Keywords: BCL-XL; Myc/B cell extra-large; b.i; bone implant; BM; bone marrow; BMD; bone mineral density; Bort; bortezomib; β2M; β2Microglobulin; Car; carfilzomib; CP; cyclophosphamide; Dex; dexamethasone; DKK1; Dickkopf-1; Dox; doxorubicin; GFP; green fluorescent